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Background: The aims of this study were to analyze plaque compsiotion of in- stent neointima within DES-treated lesions that presented with in-
stent restenosis (ISR) using IVUS RF analysis, and to evaluate their differnces according to the follow-up duration (Group A <20 months and Group B 
≥20 months ). iMAPTM is a new arlgorhythm of IVUS RF analysis to evaluate tissue characterization of the plaque obtained by 40MHz IVUS.
Method: IVUS was performed in 34 patients with 36 DES ISR lesions (Group A : 12 ISR lesions and Group B: 24 ISR lesions). Baseline clinical 
characteristics and lesion parameters were similar in the two groups. Plaque volume was calculated by IVUS and plaque components were detected 
by iMAP software. Plaques were characterized as fibrotic, lipidic, necrotic, or calcified with iMAP.
Results: Median follow up period was 42.5 months. There were no differences in amount of plaque burden (60% versus 62%, p=0.611), lipidic 
(10% verusus 12%, p=0.091), calcified (8% versus 7%, p=0.264) between the two groups. Fibrotic components were higher (59% versus 50%, 
p=0.111) in group A(<20 months), on the other hand necrotic components were significantly greater (24% versus 30%, p=0.011) in group B(≥20 
months).
Conclusion: ISR is generally considered to be a stable process with an early peak in intimal hyperplasia within the first 1 year after stent 
implantation. However, de novo in-stent neoatherosclerosis may be an important mechanism of DES failure, especially at the late phase after stent 
implantation.
 
